Danguole Vaznaisiene, Matas Simkus, Edita Druzaite, Justinas Stucinskas, Pranciskus Bakutis
{"title":"Knee Septic Arthritis Caused by Coinfection with <i>Rothia mucilaginosa</i> and <i>Erysipelothrix rhusiopathiae</i>.","authors":"Danguole Vaznaisiene, Matas Simkus, Edita Druzaite, Justinas Stucinskas, Pranciskus Bakutis","doi":"10.3390/antibiotics14090880","DOIUrl":null,"url":null,"abstract":"<p><p><b>Introduction</b>: Septic arthritis of the knee caused by the combination of <i>Rothia mucilaginosa</i> and <i>Erysipelothrix rhusiopathiae</i> is extremely rare. <i>E. rhusiopathiae</i> is a rare zoonotic pathogen that primarily affects individuals with occupational exposure to animals, while <i>R. mucilaginosa</i> can cause severe infections, particularly in immunocompromised patients. <b>Case Presentation</b>: A 59-year-old male underwent right knee arthroscopy in 2019 due to meniscal degeneration. Two weeks later, activity-related pain appeared. Magnetic resonance imaging showed proliferative synovitis, and joint aspiration revealed the presence of <i>E. rhusiopathiae</i>, which was treated with ciprofloxacin. As inflammation persisted, arthroscopic synovectomy was performed. Cultures revealed <i>R. mucilaginosa</i> and <i>E. rhusiopathiae</i>, prompting treatment with vancomycin and clindamycin. Despite repeated synovectomies, symptoms remained. After knee trauma in 2023, infection recurred. A two-stage total knee arthroplasty was performed in early 2024. At this time, another pathogen was isolated. At 12-month follow-up, the patient's function and alignment had improved significantly. <b>Conclusions</b>: The described case highlights the importance of anamnesis, early diagnostics, and knowledge about the possible resistances of rare pathogens to ensure appropriate treatment of the illness.</p>","PeriodicalId":54246,"journal":{"name":"Antibiotics-Basel","volume":"14 9","pages":""},"PeriodicalIF":4.6000,"publicationDate":"2025-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12466523/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Antibiotics-Basel","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3390/antibiotics14090880","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Septic arthritis of the knee caused by the combination of Rothia mucilaginosa and Erysipelothrix rhusiopathiae is extremely rare. E. rhusiopathiae is a rare zoonotic pathogen that primarily affects individuals with occupational exposure to animals, while R. mucilaginosa can cause severe infections, particularly in immunocompromised patients. Case Presentation: A 59-year-old male underwent right knee arthroscopy in 2019 due to meniscal degeneration. Two weeks later, activity-related pain appeared. Magnetic resonance imaging showed proliferative synovitis, and joint aspiration revealed the presence of E. rhusiopathiae, which was treated with ciprofloxacin. As inflammation persisted, arthroscopic synovectomy was performed. Cultures revealed R. mucilaginosa and E. rhusiopathiae, prompting treatment with vancomycin and clindamycin. Despite repeated synovectomies, symptoms remained. After knee trauma in 2023, infection recurred. A two-stage total knee arthroplasty was performed in early 2024. At this time, another pathogen was isolated. At 12-month follow-up, the patient's function and alignment had improved significantly. Conclusions: The described case highlights the importance of anamnesis, early diagnostics, and knowledge about the possible resistances of rare pathogens to ensure appropriate treatment of the illness.
Antibiotics-BaselPharmacology, Toxicology and Pharmaceutics-General Pharmacology, Toxicology and Pharmaceutics
CiteScore
7.30
自引率
14.60%
发文量
1547
审稿时长
11 weeks
期刊介绍:
Antibiotics (ISSN 2079-6382) is an open access, peer reviewed journal on all aspects of antibiotics. Antibiotics is a multi-disciplinary journal encompassing the general fields of biochemistry, chemistry, genetics, microbiology and pharmacology. Our aim is to encourage scientists to publish their experimental and theoretical results in as much detail as possible. Therefore, there is no restriction on the length of papers.